Awarded Contractocds-h6vhtk-051cde

Aseptically Prepared Systemic Anti-Cancer Therapy Medicines

This framework agreement is for the supply of a range of aseptically prepared, batch manufactured systemic anti-cancer therapy drugs in ready-to-administer presentations and agreed dose bands. The framework agreement will also cover the manufacturing and supply of patient specific systemic anti-cancer therapy drugs and medicines used in CIVAs.

Buyer

Mid South Essex NHS Foundation Trust

Value

£2,550,000,000

Published

13 Apr 2026

Closes

11 May 2026

Procurement details

Source

Find a Tender

Region

United Kingdom

Procurement method

Open

Category

Goods

Contract starts

1 Dec 2026

Contract ends

30 Nov 2034

CPV classifications

33600000

Pharmaceutical products

Lots

Lot 1 Dose Banded Systemic Anti-Cancer Therapy Medicines

£850,000,000

Delivery: UK · United Kingdom, UKF · United Kingdom, UKG · United Kingdom, UKJ · United Kingdom

Lot 2 Patient Specific Systemic Anti-Cancer Therapy Medicines

£850,000,000

Delivery: UKF · United Kingdom, UKG · United Kingdom, UKJ · United Kingdom

Lot 3 CIVAS (Central Intravenous Additive Service)

£850,000,000

Delivery: UKF · United Kingdom, UKG · United Kingdom, UKJ · United Kingdom

Lot 4 Stock Inventory Management and Supply of Compounded Systemic Anti-Cancer Therapy Medicines

£850,000,000

Delivery: UKF · United Kingdom, UKG · United Kingdom, UKJ · United Kingdom

Tender notice on Find a Tender

13 Apr 2026

Tender notice on Find a Tender

Tender notice · UK4 · Web page

Pipeline notice on Find a Tender

22 May 2025

Pipeline notice on Find a Tender

Planned procurement notice · UK1 · Web page

Preliminary market engagement notice on Find a Tender

12 Aug 2025

Preliminary market engagement notice on Find a Tender

Market engagement notice · UK2 · Web page

Contract award notice on Find a Tender

26 Oct 2026

Contract award notice on Find a Tender

Award notice · UK6 · Web page

Contains public sector information licensed under the Open Government Licence v3.0.